Stay updated on Oncolytics Biotech Press Releases
Sign up to get notified when there's something new on the Oncolytics Biotech Press Releases page.

Latest updates to the Oncolytics Biotech Press Releases page
- Check2 days agoChange DetectedThe investor overview lists recent clinical supply agreements and research findings, along with an upcoming annual meeting, in place of older press releases. The displayed stock price and daily change have also been updated.SummaryDifference3%

- Check9 days agoChange DetectedThe displayed stock price rose from $0.42 to $0.44, with the daily change updating from -$0.003 (-0.70%) to -$0.01 (-2.23%). The latest press release now highlights translational data showing pelareorep drives HPV-specific immune responses in anal cancer patients, replacing an update on the GOBLET study and PanCAN grant payment.SummaryDifference3%

- Check16 days agoChange DetectedThe investor overview now shows a share price of $0.42, down $0.003 (0.70%), and features an October 27, 2026 press release on pelareorep’s durability and survival data in anal cancer. It replaces the prior quote and an October 12, 2026 release about patent protection and the intellectual property portfolio.SummaryDifference3%

- Check23 days agoChange DetectedThe latest press release now highlights a planned ESMO presentation on pelareorep’s potential in colorectal cancer, replacing a release about immune responses in liver cancer. The stock quote’s daily change shifted from a decline of $0.05 (−9.12%) to a gain of $0.002 (0.40%).SummaryDifference2%

- Check30 days agoChange DetectedThe stock quote changed from $0.56, up $0.013 (2.39%), to $0.50, down $0.05 (9.12%). The latest press releases now cover a GOBLET study update and patent protection extending into the late 2040s, replacing earlier colorectal cancer study and preclinical-results announcements.SummaryDifference3%

- Check37 days agoChange DetectedOncolytics Biotech’s displayed share price changed from $0.63 to $0.56. The daily movement shifted from a $0.01 decline (−1.56%) to a $0.013 gain (+2.39%).SummaryDifference0.9%

Stay in the know with updates to Oncolytics Biotech Press Releases
Enter your email address, and we'll notify you when there's something new on the Oncolytics Biotech Press Releases page.